GSK Will Cut Sales Force And Reinvest In R&D If Pfizer Acts First
This article was originally published in The Pink Sheet Daily
Executive Summary
Company would “welcome” a decision by Pfizer to cut back its sales force, CEO Garnier declares. Analyst reports have ignited market speculation that Pfizer is ready to retool its sales and marketing infrastructure.
You may also be interested in...
Pfizer Unveils Sales Force Plan: Reorganization Involves “Modest” Cuts
The plan will be “very disappointing to our competitors,” CEO McKinnell declares. Pfizer will restructure sales force to reduce number of reps calling on individual doctors, but will not use layoffs to cut headcount significantly.
Pfizer Unveils Sales Force Plan: Reorganization Involves “Modest” Cuts
The plan will be “very disappointing to our competitors,” CEO McKinnell declares. Pfizer will restructure sales force to reduce number of reps calling on individual doctors, but will not use layoffs to cut headcount significantly.
Novartis Will Stand Tough On Sales Force Size, CEO Costa Says
Potential cuts to competitors' sales forces will give Novartis an opportunity to "leverage that asset," the exec says. Novartis' sales force continues to offer a strong return on investment, he notes.